Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Exelixis
Related studies linked through entity extraction aliases.
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Status
- RECRUITING
- Phase
- PHASE2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Cabozantinib and Pembrolizumab in Metastatic Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
- Status
- COMPLETED
- Phase
- PHASE1
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
- Status
- TERMINATED
- Phase
- PHASE1
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE2